The Oncotyrol Prostate Cancer Outcome and Policy Model - How Latent Prevalence Affects the Benefit-Harm Balance of Screening
Abstract
Authors
N. Mühlberger E.A.M. Heijnsdijk C. Kurzthaler R. Iskandar M.D. Krahn K. Bremner W. Oberaigner H. Klocker W. Horninger A. Conrads-Frank G. Sroczynski U Siebert